Nicole Selenko-Gebauer

Nicole Selenko-Gebauer currently serves as Group VP and Chief Innovation Officer for Diagnostics at Danaher Corporation, focusing on advancing diagnostic innovations and enhancing clinical strategies. In addition, Nicole acts as a Scientific Advisor for Venture Funds and Biotech, providing insights into asset biology and preclinical data for investment decisions. Previous roles include Vice President at AbbVie, overseeing R&D and leading international medical teams, and director positions at Abbott and Merck, focused on medical affairs in rheumatology and endocrinology. Nicole holds an MD in Immunology from the Medical University of Vienna and an MBA in Change Management from WU Vienna University of Economics and Business.